MedPath

Hybrid Treatment of Type B Aortic Dissection

Not Applicable
Conditions
Aortic Dissection Type B
Registration Number
NCT02726841
Lead Sponsor
Meshalkin Research Institute of Pathology of Circulation
Brief Summary

Authors hypothesize that thoracoabdominal aortic repair combined with bare metal stent implantation is superior over standard thoracoabdominal aortic repair.

Detailed Description

Main hypothesis of this study is that thoracoabdominal aortic repair combined with bare metal stent implantation is better permanent neurological deficits, perioperative bleeding, malperfusion of viscera over conventional thoracoabdominal aortic repair.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
160
Inclusion Criteria
  • Patients with chronic aortic dissection type B
  • Aortic size in descending thoracoabdominal aorta (TAA) > 55 mm
Exclusion Criteria
  • concomitant cardiac pathology
  • concomitant oncology diseases in the last 5 years
  • acute aortic dissection
  • aortic size in visceral zone >45 mm
  • connectivity tissue diseases

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Permanent neurological events30 days

Quantity of permanent neurological events such as stroke and paraplegia by 30th day after procedure.

Secondary Outcome Measures
NameTimeMethod
Mortality6 months

Postoperative mortality will be measured during 6 months after procedure

Visceral malperfusion6 months

Clinical evidences of visceral malperfusion (acute or achronic abdomen ischemia) during 6 months after procedure (Yes or No)

Perioperative bleeding5 days after procedure

Volume of perioperative and postoperative bleeding in ICU

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.